DAI Nippon Pharmaceutical revenue breakdown overview

DAI Nippon Pharmaceutical revenue for the last year amounted to 4.18 B USD, the most of which — 3.84 B USD — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 4.27 B USD. The greatest contribution to the revenue figure was made by North America — last year it brought DAI Nippon Pharmaceutical 2.47 B USD, and the year before that — 2.63 B USD.